CD226 and acute myeloid leukemia: In this study we report that DNAM-1 is frequently expressed on AML patient cells, demonstrate that DNAM-1 stimulates the production of immunomodulatory cytokines by the leukemic cells and identified a significant correlation of DNAM-1 with disease outcome.